CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese

Atherosclerosis

Volumn 120, Issue 1-2, 1996, Pages 75-82

  Kinoshita, Makoto ^a   Teramoto, Tamio ^a   Shimazu, Nobuko ^a   Kaneko, Kazuko ^a   Ohta, Masato ^b   Koike, Toru ^b   Hosogaya, Shigemi ^b   Ozaki, Yukio ^b   Kume, Shoji ^b   Yamanaka, Masami ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Alcohol intake; Apolipoproteins; Cholesteryl ester transfer protein; Cigarette smoking; Lipoproteins; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0030052855     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05684-X     Document Type: Article

References (28)

1. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993;34:1255.
2. Tall AR. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest 1990;86:379.
3. Yamashita S, Hui DY, Sprecher DL, Matsuzawa Y, Sakal N, Tarui S, Kaplan D, Wetterau JR, Harmony JAK. Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect. Biochem Biophy Res Commun 1990;170:1346.
4. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR. Increased high density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990;323:1234.
5. Koizumi J, Inazu A, Yagi K, Koizumi I, Uno Y, Kajinami K, Miyamoto S, Moulin P, Tall AR, Mabuchi H, Takeda R. Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. Atherosclerosis 1991;90:189.
6. Ikewaki K, Rader DJ, Sakamoto T, Nishiwaki M, Wakimoto N, Schaefer JR, Ishikawa T, Fairwell T, Zech LA, Nakamura H, Nagano, M, Brewer HB Jr. Delayed catabolism of high density lipoprotein apolipoprotein, A-I and, A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest 1993;92:1650.
7. Agellon LB, Walsh A, Hayek T, Moulin P, Jiang XC, Shelanski SA, Breslow JL, Tall AR. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem 1991;266:10796.
8. Sakai N, Matsuzawa Y, Hirano S, Yamashita S, Nozaki Y, Ueyama M, Kubu M, Tarui S. Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency. Arterioscler Thromb 1991;11:71.
9. McPherson R, Hogue M, Milne RW, Tall AR, Marcel YL. Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition. Arterioscler Thromb 1991;11:476.
10. Franceschini G, Chiesa G, Sirtori CR. Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patient. Eur J Clin Invest 1991;21:384.
11. Hannuksela M, Marcel YL, Kasaniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992;33:737.
12. Hirano K, Matsuzawa Y, Sakai N, Hiraoka H, Nozaki S, Funahashi T, Yamashita S, Kubo M, Tarui S. Polydisperse low-density lipoprotein in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity. Metabolism 1992;41:1313.
13. Friedwald WT, Levy RI, Fredrickson DS. Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem 1972;18:499.
14. Rifai N, Silverman LM. Immunoturbidimetric techniques for quantifying apolipoprotein, C-II and, C-III. Clin Chem 1986;32:1969.
15. Nagasaki T, Akanuma Y. A new colorimetric method for the determination of plasma lecithin-cholesterol acyltransferase activity. Clin Chem Acta 1977;75:371.
16. Kinoshita M, Arai H, Fukasawa M, Watanabe T, Tsukamoto K, Hashimoto Y, Inoue K, Kurokawa K, Teramoto T. Apolipoprotein E enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein. J Lipid Res 1993;34:261.
17. Sato T, Fukasawa M, Kinoshita M, Arai H, Saeki T Naraki T, Iwasaki Y, Teramoto T, Takahashi K, Saito Y, Inoue K. Enzyme-linked immunosorbant assay for cholesteryl ester transfer protein in human serum Clin Chim Acta 1995;240:1.
18. Quinet E, Tall A, Ramakrishnan R, Rudel L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest 1991;87:1559.
19. Pittman RC, Knecht TP, Rosenbaum MS, Taylor CA Jr. A. nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. J Biol Chem 1987;262:2443.
20. Gupta AK, Ross EA, Myers JN, Kashyap ML. Increased reverse cholesterol transport in athletes. Metabolism 1993;42:684.
21. Silliman K, Tall AR, Kretchmer N, Forte TM. Unusual high-density lipoprotein subclasses distribution during late pregnancy. Metabolism 1993;42:1592.
22. Marcel YL, McPherson R, Hogue M, Czarnecka H, Zawadski Z, Weech PK, Whitlock ME, Tall AR, Milne RW. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J Clin Invest 1990;85:10.
23. Iglesias A, Montelongo A, Herrera E, Lasuncion MA. Changes in cholesteryl ester transfer protein activity during normal gestation and postpartum. Clin Biochem 1994;27:63.
24. Dullaart RPF, Hoogenberg K, Dikkeschei BD, Tol AV. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb 1994;14:1581.
25. Freeman DJ, Griffin BA, Murray E, Lindsay GM, Gaffney D, Packard CJ, Shephard J. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest 1993;23:630.
26. Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Tol AV. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994;24:188.
27. Arai T, Yamashita S, Hirano K, Sakai N, Kotani K, Fujioka S, Nozaki S, Keno Y, Yamane M, Shinohara E, Islam AHMW, Ishigami M, Nakamura T, Takemura KK, Tokunaga K, Matsuzawa Y. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction oh serum, HDL cholesterol levels in obesity. Arterioscler Thromb 1994;14:1129.
28. McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne RW, Marcel YL. Plasma concentration of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variable. Arterioscler Thromb 1991;11:797.